Matches in SemOpenAlex for { <https://semopenalex.org/work/W54562364> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W54562364 abstract "Our previous study shows that hyperglycemia impairs myocardial angiogenesis via impairment of angiopoietin-1(Ang-1)/Akt/eNOS phosphorylation. Protein tyrosine phosphatase (PTP) plays an essential role in intracellular signal transduction by regulating tyrosine phosphorylation. PTP inhibitor has been shown to modulate Akt/eNOS phosphorylation, but little is known about the inhibition of PTP on angiogenesis under hyperglycemic conditions. We investigated the role of inhibition of PTP on hyperglycemia-induced impairment of angiogenic signaling pathways and angiogenesis. Our data demonstrate that exposure of mouse heart microvascular endothelial cells (MHMECs) to hyperglycemia leads to an increase in caspase-3 activity. Pretreatment of cells with the protein tyrosine phosphatase inhibitor, sodium orthovanadate (OV, 5 μM), significantly enhances the Ang-1-inhibitory effect on caspase-3 activity both under normal or hyperglycemic conditions. Pretreatment of MHMEC with the PTP inhibitor OV (0.5–20 μM) significantly enhances cell survival in a dose dependent manner under hyperglycemic conditions as measured by MTT assay. Pretreatment of MHMEC with OV (5 μM) enhances the effect of Ang-1 on endothelial cell survival under hyperglycemic conditions. As expected, Ang-1-induced Akt and eNOS phosphorylation is minimal under hyperglycemic conditions. Pretreatment of MHMEC with OV (5 μM) for 30 minutes leads to an increase in Akt phosphorylation at baseline and augments Ang-1-induced Akt and eNOS phosphorylation under hyperglycemic conditions. Additionally, systemic administration of bis(maltolato) oxovanadium(IV) (BMOV, 0.2g/L) in db/db mice results in a dramatic decrease in plasma glucose levels and an increase in vessel outgrowth in response to Ang-1 (250 ng/ml) stimulation. Treatment of db/db mice with BMOV significantly increases myocardial ischemia-induced HIF expression. Furthermore, bone marrow differentiation into endothelial cell progenitor cell is also significantly improved in the BMOV treated db/db mice. Our data implicate that upregulation of Ang-1/Akt/eNOS phosphorylation by PTP inhibitors should be considered as a new therapeutic strategy for the treatment or prevention of diabetic impaired angiogenesis." @default.
- W54562364 created "2016-06-24" @default.
- W54562364 creator A5018208620 @default.
- W54562364 creator A5049273073 @default.
- W54562364 creator A5064704246 @default.
- W54562364 date "2007-10-16" @default.
- W54562364 modified "2023-09-26" @default.
- W54562364 title "Abstract 227: Inhibition Of Protein Tyrosine Phosphatase Improves Hyperglycemic Impaired Angiogenesis" @default.
- W54562364 doi "https://doi.org/10.1161/circ.116.suppl_16.ii_25" @default.
- W54562364 hasPublicationYear "2007" @default.
- W54562364 type Work @default.
- W54562364 sameAs 54562364 @default.
- W54562364 citedByCount "0" @default.
- W54562364 crossrefType "journal-article" @default.
- W54562364 hasAuthorship W54562364A5018208620 @default.
- W54562364 hasAuthorship W54562364A5049273073 @default.
- W54562364 hasAuthorship W54562364A5064704246 @default.
- W54562364 hasConcept C11960822 @default.
- W54562364 hasConcept C126322002 @default.
- W54562364 hasConcept C134018914 @default.
- W54562364 hasConcept C170493617 @default.
- W54562364 hasConcept C178666793 @default.
- W54562364 hasConcept C2777553839 @default.
- W54562364 hasConcept C2777622882 @default.
- W54562364 hasConcept C2778326061 @default.
- W54562364 hasConcept C2779417574 @default.
- W54562364 hasConcept C2780394083 @default.
- W54562364 hasConcept C519581460 @default.
- W54562364 hasConcept C62478195 @default.
- W54562364 hasConcept C71924100 @default.
- W54562364 hasConcept C75217442 @default.
- W54562364 hasConcept C85528070 @default.
- W54562364 hasConcept C86554907 @default.
- W54562364 hasConcept C86803240 @default.
- W54562364 hasConcept C95444343 @default.
- W54562364 hasConcept C98274493 @default.
- W54562364 hasConceptScore W54562364C11960822 @default.
- W54562364 hasConceptScore W54562364C126322002 @default.
- W54562364 hasConceptScore W54562364C134018914 @default.
- W54562364 hasConceptScore W54562364C170493617 @default.
- W54562364 hasConceptScore W54562364C178666793 @default.
- W54562364 hasConceptScore W54562364C2777553839 @default.
- W54562364 hasConceptScore W54562364C2777622882 @default.
- W54562364 hasConceptScore W54562364C2778326061 @default.
- W54562364 hasConceptScore W54562364C2779417574 @default.
- W54562364 hasConceptScore W54562364C2780394083 @default.
- W54562364 hasConceptScore W54562364C519581460 @default.
- W54562364 hasConceptScore W54562364C62478195 @default.
- W54562364 hasConceptScore W54562364C71924100 @default.
- W54562364 hasConceptScore W54562364C75217442 @default.
- W54562364 hasConceptScore W54562364C85528070 @default.
- W54562364 hasConceptScore W54562364C86554907 @default.
- W54562364 hasConceptScore W54562364C86803240 @default.
- W54562364 hasConceptScore W54562364C95444343 @default.
- W54562364 hasConceptScore W54562364C98274493 @default.
- W54562364 hasIssue "suppl_16" @default.
- W54562364 hasLocation W545623641 @default.
- W54562364 hasOpenAccess W54562364 @default.
- W54562364 hasPrimaryLocation W545623641 @default.
- W54562364 hasRelatedWork W1552456029 @default.
- W54562364 hasRelatedWork W2013263772 @default.
- W54562364 hasRelatedWork W2040435120 @default.
- W54562364 hasRelatedWork W2049367486 @default.
- W54562364 hasRelatedWork W2058227667 @default.
- W54562364 hasRelatedWork W2151643728 @default.
- W54562364 hasRelatedWork W2163109084 @default.
- W54562364 hasRelatedWork W2407647457 @default.
- W54562364 hasRelatedWork W2414885795 @default.
- W54562364 hasRelatedWork W54562364 @default.
- W54562364 hasVolume "116" @default.
- W54562364 isParatext "false" @default.
- W54562364 isRetracted "false" @default.
- W54562364 magId "54562364" @default.
- W54562364 workType "article" @default.